Abstract:A central hallmark of neurodegenerative diseases is the irreversible accumulation of misfolded proteins in the brain by aberrant phosphorylation. Understanding the mechanisms underlying protein phosphorylation and its role in pathological protein aggregation within the context of aging is crucial for developing therapeutic strategies aimed at preventing or reversing such diseases. Here, we applied multi-protease digestion and quantitative mass spectrometry to compare and characterize dysregulated proteins and phosphosites in the mouse brain proteome using three different age groups: young-adult (3-4 months), middle-age (10 months), and old mice (19-21 months). Proteins associated with senescence, neurodegeneration, inflammation, cell cycle regulation, the p53 hallmark pathway, and cytokine signaling showed significant age-dependent changes in abundances and level of phosphorylation. Several proteins implicated in Alzheimer's disease (AD) and Parkinson's disease (PD) including tau (Mapt), Nefh, and Dpysl2 (also known as Crmp2) were hyperphosphorylated in old mice brain suggesting their susceptibility to the diseases. Cdk5 and Gsk3b, which are known to phosphorylate Dpysl2 at multiple specific sites, had also increased phosphorylation levels in old mice suggesting a potential crosstalk between them to contribute to AD. Hapln2, which promotes α-synuclein aggregation in patients with PD, was one of the proteins with highest abundance in old mice. CD9, which regulates senescence through the PI3K-AKT-mTOR-p53 signaling was upregulated in old mice and its regulation was correlated with the activation of phosphorylated AKT1. Overall, the findings identify a significant association between aging and the dysregulation of proteins involved in various pathways linked to neurodegenerative diseases with potential therapeutic implications.

Aging and neurodegeneration: From molecular mechanisms to therapeutic interventions

Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics

Glycosylation in aging and neurodegenerative diseases

Protein aggregation and its affecting mechanisms in neurodegenerative diseases

Role of Protein Misfolding and Proteostasis Deficiency in Protein Misfolding Diseases and Aging

The interplay between aging-associated loss of protein homeostasis and extracellular vesicles in neurodegeneration

Misfolded Protein Aggregation and Altered Cellular Pathways in Neurodegenerative Diseases

Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View

Mechanisms of neuroplasticity and brain degeneration: strategies for protection during the aging process

Autophagy in Aging and Neurodegenerative Diseases: Implications for Pathogenesis and Therapy.

Mitochondrial Dynamics and Proteins Related to Neurodegenerative Diseases

Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets

Progressing neurobiological strategies against proteostasis failure: Challenges in neurodegeneration

Proteostasis disruption and senescence in Alzheimer's disease pathways to neurodegeneration

Molecular and Cellular Foundations of Aging of the Brain: Anti-aging Strategies in Alzheimer's Disease

Insights into Molecular, Cellular, and Systemic Mechanisms

Autophagy, aging, and age-related neurodegeneration

Molecular insights into aggrephagy: Their cellular functions in the context of neurodegenerative diseases

Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression

Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases

Molecular Signatures of Neurodegenerative Diseases Identified by Proteomic and Phosphoproteomic Analyses in Aging Mouse Brain